[Federal Register: May 9, 2005 (Volume 70, Number 88)]
[Notices]               
[Page 24455]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09my05-82]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 28, 2004, and published in the Federal 
Register on July 13, 2004, (69 FR 42068), Eli-Elsohly Laboratories, 
Inc., Mahmoud A. Elsohly PhD., 5 Industrial Park Drive, Oxford, 
Mississippi 38655, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in Schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for use in analysis and drug test standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Eli-Elsohly Laboratories, Inc. to manufacture the listed basic classes 
of controlled substances is consistent with the public interest at this 
time. DEA has investigated Eli-Elsohly Laboratories, Inc. to ensure 
that the company's registration is consistent with the public interest. 
The investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33(a), the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: May 2, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-9177 Filed 5-6-05; 8:45 am]

BILLING CODE 4410-09-P